Use and misuse of common terminology criteria for adverse events in cancer clinical trials

Gelijkaardige items

• Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials
  door: Lauren Rogak, et al.
  Gepubliceerd in: (2025-10-01)
• Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events
  door: Miller, Tamara P., et al.
  Gepubliceerd in: (2019)
• ReCAP: Identifying Severe Adverse Event Clusters Using the National Cancer Institute’s Common Terminology Criteria for Adverse Events
  door: Zhong, Xiaobo, et al.
  Gepubliceerd in: (2016)
• Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
  door: Chung, Arlene E, et al.
  Gepubliceerd in: (2019)
• Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
  door: Reeve, Bryce B, et al.
  Gepubliceerd in: (2020)